This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Gilead Sciences, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Katherine De La Fuente: Innovator in Antiviral Compounds
Introduction
Katherine De La Fuente is a prominent inventor based in Foster City, CA (US). She has made significant contributions to the field of antiviral research, particularly through her innovative work on indoliny compounds.
Latest Patents
Katherine holds a patent for "Antiviral Indoliny Compounds and Uses Thereof." This patent represents her commitment to developing effective antiviral agents that can combat various viral infections.
Career Highlights
Katherine is currently employed at Gilead Sciences, Inc., a leading biopharmaceutical company known for its focus on antiviral drugs. Her work at Gilead has positioned her as a key player in the development of new therapeutic options.
Collaborations
Throughout her career, Katherine has collaborated with notable colleagues, including William John Watkins and Aesop Cho. These partnerships have enhanced her research and contributed to the advancement of antiviral therapies.
Conclusion
Katherine De La Fuente's innovative work in antiviral compounds showcases her dedication to improving public health through scientific research. Her contributions are vital in the ongoing fight against viral diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile